Risk Factors Associated With Ischemic Stroke in Japanese Patients With Nonvalvular Atrial Fibrillation.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 04 2020
Historique:
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 23 10 2020
Statut: epublish

Résumé

Despite the development of risk stratification schemes that have been widely used to determine the risk for thromboembolism in patients with nonvalvular atrial fibrillation (NVAF), risk stratification schemes in Asian patients with NVAF remain undetermined. To determine risk factors for ischemic stroke in Japanese patients with NVAF. This cohort study analyzed individual patient data from 5 AF registries in Japan: J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Registry, Fushimi AF Registry, Shinken Database, Keio Interhospital Cardiovascular Studies (Keio Study), and Hokuriku-Plus AF Registry. Patients with atrial fibrillation were registered from 158 institutions in the J-RHYTHM Registry, 80 in the Fushimi AF Registry, a single hospital in Shinken Database, 11 in the Keio Study, and 19 in the Hokuriku-Plus AF Registry. Patients with valvular AF or lacking data were excluded. Data were collected and integrated in March 2016, and those from the Keio Study were updated in April 2018. Data were analyzed from April 2018 to February 2020. Significant risk factors for ischemic stroke were determined by adjusted Cox proportional hazards analysis. In total, 12 289 patients with NVAF (3758 [31%] female; mean [SD] age 70.2 [11] years) were analyzed with a mean (SD) follow-up period of 649 (181) days (1.8 [0.5] years). During 21 820 person-years of follow-up, 241 cases of ischemic stroke were reported. Risk factors associated with ischemic stroke after adjustment for oral anticoagulant use at enrollment were age (75-84 years: hazard ratio [HR], 1.74; 95% CI, 1.32-2.30; P < .001; and ≥85 years: HR, 2.41; 1.63-3.56; P < .001), hypertension (HR, 1.60; 95% CI, 1.15-2.23; P = .006), previous stroke (HR, 2.75; 95% CI, 2.09-3.62; P < .001), persistent or permanent AF (HR, 1.59; 95% CI, 1.21-2.10; P = .001), and body mass index less than 18.5 (HR, 1.55; 95% CI, 1.05-2.29; P = .03). Neither diabetes nor heart failure were identified as risk factors for ischemic stroke. Previous stroke, advanced age, hypertension, persistent or permanent AF, and low body mass index were independent risk factors associated with ischemic stroke in Japanese patients with NVAF.

Identifiants

pubmed: 32293685
pii: 2764403
doi: 10.1001/jamanetworkopen.2020.2881
pmc: PMC7160687
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202881

Références

Circulation. 2018 Feb 20;137(8):832-840
pubmed: 29459469
Chest. 2016 Feb;149(2):401-412
pubmed: 26181726
Circ J. 2015;79(5):1009-17
pubmed: 25740669
Circ J. 2014;78(7):1593-9
pubmed: 24759791
J Cardiol. 2013 Apr;61(4):260-6
pubmed: 23403369
Am J Hypertens. 2017 Nov 1;30(11):1073-1082
pubmed: 28575205
Circ J. 2011;75(6):1328-33
pubmed: 21467664
J Am Heart Assoc. 2016 Sep 09;5(9):
pubmed: 27613773
Europace. 2016 Nov;18(11):1609-1678
pubmed: 27567465
Circ J. 2018 Apr 25;82(5):1327-1335
pubmed: 29526914
J Am Coll Cardiol. 2017 Jan 31;69(4):409-419
pubmed: 28126158
Eur Heart J Qual Care Clin Outcomes. 2018 Jan 1;4(1):59-68
pubmed: 28950373
Eur Heart J. 2016 May 21;37(20):1591-602
pubmed: 26888184
J Am Heart Assoc. 2016 Sep 12;5(9):
pubmed: 27620886
J Cardiol. 2011 Sep;58(2):116-23
pubmed: 21820280
Circ J. 2015;79(8):1719-26
pubmed: 25971525
J Am Coll Cardiol. 2019 Mar 5;73(8):919-931
pubmed: 30819360
Eur Heart J. 2015 Feb 1;36(5):288-96
pubmed: 25209598
Circ J. 2018 Apr 25;82(5):1271-1278
pubmed: 29491320
BMC Cardiovasc Disord. 2019 Nov 27;19(1):283
pubmed: 31810439
Circ J. 2015;79(2):432-8
pubmed: 25501800
Am J Cardiol. 2017 Apr 15;119(8):1229-1237
pubmed: 28219663
Circulation. 2019 Jul 9;140(2):e125-e151
pubmed: 30686041
Circ J. 2014;78(8):1997-2021
pubmed: 24965079
JAMA. 2001 Jun 13;285(22):2864-70
pubmed: 11401607
Circ Arrhythm Electrophysiol. 2017 Jan;10(1):
pubmed: 28077507
PLoS One. 2015 Nov 05;10(11):e0142394
pubmed: 26540107
Stroke. 2015 Dec;46(12):3354-61
pubmed: 26514188
JAMA Netw Open. 2019 Mar 1;2(3):e191145
pubmed: 30924896

Auteurs

Ken Okumura (K)

Department of Cardiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Division of Cardiology, Saiseikai Kumamoto Hospital, Kumamoto, Japan.

Hirofumi Tomita (H)

Department of Cardiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Michikazu Nakai (M)

Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center, Suita, Japan.

Eitaro Kodani (E)

Department of Internal Medicine and Cardiology, Nippon Medical School Tama-Nagayama Hospital, Tokyo, Japan.

Masaharu Akao (M)

Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Shinya Suzuki (S)

Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.

Kenshi Hayashi (K)

Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.

Mitsuaki Sawano (M)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Masahiko Goya (M)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Takeshi Yamashita (T)

Department of Cardiovascular Medicine, The Cardiovascular Institute, Tokyo, Japan.

Keiichi Fukuda (K)

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Hisashi Ogawa (H)

Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.

Toyonobu Tsuda (T)

Department of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.

Mitsuaki Isobe (M)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
Sakakibara Heart Institute, Tokyo, Japan.

Kazunori Toyoda (K)

Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Yoshihiro Miyamoto (Y)

Department of Preventive Cardiology, National Cerebral and Cardiovascular Center, Suita, Japan.

Hiroaki Miyata (H)

Department of Health Policy and Management School of Medicine, Keio University, Tokyo, Japan.

Tomonori Okamura (T)

Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo, Japan.

Yusuke Sasahara (Y)

Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH